Gail Mandel
Angel investor in Morristown
Morristown, New Jersey
Gail Mandel, Angel investor in Morristown is an active investor based in Morristown, New Jersey. This profile covers what Gail Mandel backs, at which stage, and how founders can reach out in 2026.
Dr Gail Mandel serves as Chief Executive Officer at RCI. She is a Scientific Co-Founder of Vico Therapeutics. She also served as Board Member at PureStar Group. She earned her Ph.D. in Immunology at UCLA and did her postdoctoral training in biochemistry and molecular biology at UCLA and UCSD. Following an Instructor position at Harvard Medical School, she was hired as an Assistant Professor by Tufts Medical School in Boston, where she was one of the first investigators to clone and express mammalian voltage-dependent ion channels, critical for nervous system function. In the Department of Neurobiology & Behavior at Stony Brook, where she was hired at the rank of Associate Professor and ultimately promoted to Professor and Distinguished Professor, her lab identified and characterized the nuclear protein REST, which is responsible for the regulation of sodium channel expression and the acquisition of cellular excitability, as well as for regulation of many other genes critical for unique neuronal functions. These discoveries and others helped unlock fundamental mechanisms through which embryonic cell types differentiate specifically into neurons. At the Vollum Institute, in Oregon Health and Science University, where Gail is a Senior Scientist and Professor of Biochemistry, her lab continues to study the role of REST in the context of cancer and human aging and cognitive decline. She has also maintained long-standing interests in the contributions of non-neuronal cell types, such as glia, to brain function, as well as the use of animal model systems, zebrafish and mouse, to identify genes, previously unappreciated, which are critical for nervous system function. Finally, Gail has initiated studies to understand the molecular basis of, and treat, the neurological disease, Rett syndrome which involves both neurons and glia. Gail is an alumnus of the Howard Hughes Medical Institute and is a member of both the American Academy of Sciences and the National Academy of Sciences.
- Investor type
- Angel
- Stages
- Early Stage Venture
- Invests in
- Healthcare & BiotechBiotech & PharmaTravel & HospitalityGaming & EntertainmentConsumer & Retail
- Location
- Morristown, New Jersey
- Typical check
- $500K
- Past investments
- 5
Notable investments
How to reach Gail Mandel
Angels and operators like Gail Mandel reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Reach active investors like this one
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Gail Mandel." Round Funded investor database, updated September 9, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/investor/gail-mandel-277103-8
Frequently Asked Questions
What does Gail Mandel invest in?
Gail Mandel invests in Healthcare & Biotech, Biotech & Pharma, Travel & Hospitality and Gaming & Entertainment, typically at Early Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Gail Mandel invest at?
Gail Mandel typically invests at Early Stage Venture. Lead with traction that fits the stage when you reach out.
What is Gail Mandel's typical check size?
Gail Mandel typically writes checks around $500K. Use it as a signal for whether your raise fits their stage.
How do founders reach investors like this?
Round Funded lists active investors with verified, professional contact details for signed-up founders. Filter by sector, stage and location, then send a personalized pitch from your own inbox.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.